Skip to main content

Table 1 The description of the study population

From: Use of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis

 

Total

 

Receiving varenicline

 

n

%

n

%

Total

477620

 

19316

4.04

Age groups, years

    

16-30

126382

26.5

3593

2.84

31-45

139778

29.3

7004

5.01

46-60

125127

26.2

6118

4.89

>60

86333

18.1

2601

3.01

Sex

    

Male

237709

50.0

7861

3.57

Female

239911

50.0

8730

4.05

Lifestyle

    

Alcohol

15132

3.2

457

3.02

Heavy smoker

56619

11.9

4564

8.06

Obesity

45805

9.6

1901

4.15

Medical condition

    

Asthma

71759

15.0

3494

4.87

Atrial fibrillation

4629

1.0

105

2.27

Cancer

10862

2.3

457

4.21

CHD

17271

3.6

706

4.09

CKD

12313

2.6

307

2.49

COPD

22227

4.7

1511

6.80

Dementia

4198

0.9

79

1.88

Depression/anxiety

144520

30.3

6202

4.29

Diabetes

22817

4.8

931

4.08

Epilepsy

5433

1.1

108

1.99

Heart failure

3452

0.7

78

2.26

Hypertension

59505

12.5

2054

3.45

Learning disability

1239

0.3

15

1.21

Psychotic disorders

7544

1.6

81

1.07

Stroke or TIA

10979

2.3

430

3.92

Thyroid

19394

4.1

818

4.22